Anesthesia's Effects on Plasma Glucose and Insulin and Cardiac Hexokinase at Similar Hemodynamics and Without Major Surgical Stress in Fed Rats
- 1 January 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesia & Analgesia
- Vol. 106 (1), 135-142
- https://doi.org/10.1213/01.ane.0000297299.91527.74
Abstract
BACKGROUND: Recent evidence suggests that hexokinase mitochondria association attenuates cell death, and that plasma glucose and insulin concentrations can influence clinical outcome. In the present study, we examined how different anesthetics per se affect these variables of glucose metabolism, i.e., under similar hemodynamic conditions and in the absence of major surgical stress. METHODS: In fed rats, the effects of pentobarbital (PENTO), isoflurane (ISO), sevoflurane (SEVO), ketamine-medetomidine-atropine (KMA), and sufentanil-propofol-morphine (SPM) on the cardiac cellular localization of hexokinase (HK) and levels of plasma glucose and insulin were determined and compared with values obtained in nonanesthetized animals (control). The role of mitochondrial and sarcolemmal KATP-channels and α2-adrenergic receptor in ISO-induced hyperglycemia was also evaluated. RESULTS: Mean arterial blood pressure was similar among the different anesthetic strategies. PENTO (5.3 ± 0.2 mM) and SPM (5.1 ± 0.2 mM) had no significant effect on plasma glucose when compared with control (5.6 ± 0.1 mM). All other anesthetics induced hyperglycemia: 7.4 ± 0.2 mM (SEVO), 9.9 ± 0.3 mM (ISO), and 14.8 ± 1.0 mM (KMA). Insulin concentrations were increased with PENTO (2.13 ± 0.13 ng/mL) when compared with control (0.59 ± 0.22 ng/mL), but were unaffected by the other anesthetics. Inhibition of the mitochondrial KATP channel (5-hydroxydecanoate acid) or the α2-adrenergic receptor (yohimbine) did not prevent ISO-induced hyperglycemia. Only the nonspecific KATP channel inhibitor glibenclamide was able to prevent hyperglycemia by ISO. Cytoslic HK relative to total HK increased in the following sequence: control (35.5% ± 2.1%), SEVO (35.5% ± 2.7%), ISO (36.6% ± 1.7%), PENTO (41.2% ± 2.0%; P = 0.082 versus control), SPM (43.0% ± 1.8%; P = 0.039 versus control), and KMA (46.6 ± 2.3%; P = 0.002 versus control). CONCLUSIONS: Volatile anesthetics and KMA induce hyperglycemia, which can be explained, at least partly, by impaired glucose-induced insulin release. The data indicate that the inhibition of insulin release by ISO is mediated by sarcolemmal KATP channel activation. The use of PENTO and SPM is not associated with hyperglycemia. SPM and KMA reduce the antiapoptotic association of HK with mitochondria.Keywords
This publication has 39 references indexed in Scilit:
- Thinking Like a Pancreas: Perioperative Glycemic ControlAnesthesia & Analgesia, 2007
- The Physiologic Effects of Isoflurane Anesthesia in Neonatal MiceAnesthesia & Analgesia, 2006
- Insulin secretion and glucose utilization are impaired under general anesthesia with sevoflurane as well as isoflurane in a concentration-independent mannerJournal of Anesthesia, 2005
- Effects of anesthetics on systemic hemodynamics in miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Mitochondrial Bound Hexokinase Activity as a Preventive Antioxidant DefenseJournal of Biological Chemistry, 2004
- The New Anesthesia Diet Plan: Keeping Perioperative Carbs in CheckAnesthesia & Analgesia, 2004
- Elevation of Blood Glucose Following Anaesthetic Treatment in C57Bl/6 MiceHormone and Metabolic Research, 2004
- Delta opioid agonists and volatile anesthetics facilitate cardioprotection via potentiation of K ATP channel openingThe FASEB Journal, 2002
- The Effects of Sevoflurane Anesthesia on Insulin Secretion and Glucose Metabolism in PigsAnesthesia & Analgesia, 1997
- Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioningCardiovascular Research, 1994